Genetic Analysis has developed and launched the first gene-based routine test for the mapping and aide in diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system.

A standardized and robust technology makes it possible to compare bacteria profiles in patients to bacteria profiles of control populations as well as in patient groups before and after treatment. A standardized reproducible method is critical in order to discover links between the microbiota, clinical conditions and treatment.

The company markets the CE marked GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis was established in 2008 and is based on research done by Professor Knut Rudi at Norwegian University of Life Sciences.